2305.T
2305.T
JP3399240005
STUDIO ALICE
Loading chart...
Solid Quality Asset with Moderate Fluctuation

Healthy balance: Exemplary business financials (Health Score: 85/100) paired with moderate price swings for a single equity (±14.5% p.a.). The score (5/7) reflects the standard baseline for equities under SRI rules.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
5/7 Elevated
5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.0x).

Beta (Market Relation)
0.01x
Defensive
Volatility (5Y p.a.)
14.5% p.a.
5-Year Horizon
Max Drawdown (5Y)
-27.3%
5-Year Horizon
Sharpe Ratio
-0.49
Return / Risk
Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -12.4%
3 Years 11.4% -20.0% -0.64 -4.8%
5 Years 14.5% -27.3% -0.49 -4.6%
10 Years 20.6% -55.5% -0.21 -1.9%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Strong cyclicality: The business model is sensitive to economic downturns.
Historical Stress Test: Maximum peak-to-trough drawdown of -55.5% in the extended horizon.
ende